Efficacy of ombitasvir/paritaprevir/ritonavir/ribavirin in management of HCV genotype 4 and end-stage kidney disease
about
Efficacy of ombitasvir/paritaprevir/ritonavir/ribavirin in management of HCV genotype 4 and end-stage kidney disease
description
scientific article published on 27 August 2018
@en
name
Efficacy of ombitasvir/paritap ...... 4 and end-stage kidney disease
@en
type
label
Efficacy of ombitasvir/paritap ...... 4 and end-stage kidney disease
@en
prefLabel
Efficacy of ombitasvir/paritap ...... 4 and end-stage kidney disease
@en
P2093
P1476
Efficacy of ombitasvir/paritap ...... 4 and end-stage kidney disease
@en
P2093
Abdel-Kader A Hashim
Essam M Abdel-Aziz
Heba A Osman
Khairy H Morsy
Mohamed O Abdel-Malek
P356
10.1016/J.CLINRE.2018.08.003
P577
2018-08-27T00:00:00Z